The use of combined drugs as a component of complex therapy of inflammatory diseases of the pharynx: A review

Unfortunately, the occurrence of various pathologies in the ENT organs still remains one of the pressing problems in global healthcare. The frequent manifestation of unwanted pathologies forces us to change methods, and sometimes to introduce something new into the medical care provided to patients. Researchers from the Center for Medical Statistics of the Scientific Research Institute of Medical Sciences and Medical Research, Moscow Health Department, having conducted a detailed analysis of the activities of otorhinolaryngological departments in medical organizations in the city of Moscow, found that in 2022 the number of all visits to otorhinolaryngologists exceeded 4.5 million, of which 45.7% were children, and 54.2% were committed by persons over 18 years of age. Preventive visits of patients to doctors for 2018–2022 increased from 29.3 to 37.8%. Infectious and inflammatory diseases of the oral cavity and pharynx are among the most common diseases of the ENT organs. Given the proliferation, development of technology and possible tensions, they still remain a pressing issue. That is why various new options for drug therapy are being proposed that would be most effective, and one of these new drugs is Lorothricin, a combination drug that has shown itself to be the best in a number of studies and clinical cases. In a review article, based on our experience and literature data. We present the problem of treating patients with sore throat due to acute pharyngitis, tonsillitis and gingivitis.